glp receptor 1 agonists Glucagon-like peptide-1 (GLP-1) are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and #obesity. GLP-1 receptor agonists and GLP-1 and glucose-dependent insulinotropic 𝗧𝗵𝗲 𝗘𝗳𝗳𝗲𝗰𝘁 𝗼𝗳 𝗚𝗟𝗣-𝟭 𝗥𝗲𝗰𝗲𝗽𝘁𝗼𝗿

Retatrutide is the first medication in this class that hits 3 different biological targets

Glucagon-like peptide-1 receptor agonists: A narrative review of clinical pharmacology and implications for peri-operative practice

Please note that compounded medications are sourced from licensed US pharmacies, but they are not FDA approved and may not be available in every state

Clarke, S

You may also be able to use HSA or FSA funds to pay for your medication

GLP-1RAs hold promise as dual-action agents in IBD, offering potential benefits in metabolic control, weight loss, and disease modulation through immunological and barrier-enhancing effects